COVID-19: epidemiological update. Weekly report. Week 39. 6 October 2022.
Key points
In week 39, circulation of SARS-CoV-2 increased significantly throughout metropolitan France, particularly among the elderly. Hospital indicators also continued to rise.
Metropolitan France:
Continued rise in incidence rate, except in the under-20 age group
Sharp increase in incidence rate among the elderly
Rise in hospital admissions and deaths
Overseas France:
Incidence rate in decline across all territories
Variants
Omicron sub-lineages: BA.5 omnipresent, accounting for 91% of sequences in the week 38 Flash Survey (19 September)
Prevention
Vaccination on 3 October 2022 (Vaccin Covid data):
74.4% of the population aged 18+ and 82.5% of the 65+ age group had received a first booster dose
29.8% of 60-79 year-olds (representing 35.3% of those eligible given the date of their last injection) and 37.3% of people aged 80+ (48.8% of those eligible) had received a second booster dose
CoviPrev Survey wave 35 (12 to 19 September):
Further decline in application of protective measures, particularly wearing a face mask
Less than half of those at risk for severe forms of influenza intend to get vaccinated for influenza and COVID-19
Given the intensified circulation of SARS-CoV-2, compliance with the combined measures remains crucial:
up-to-date COVID-19 vaccination, including a booster dose of a bivalent vaccine (protecting against the original strain and the Omicron variant of SARS-CoV-2) for those eligible and already vaccinated with a primary course;
self-isolation in case of a positive test for COVID-19 and/or symptoms;
continued application of precautionary measures, including wearing a face mask, particularly around vulnerable people and in enclosed spaces favourable to transmission (public transport, large gatherings, etc.), frequent hand washing and ventilation of interiors.
En relation avec
Nos dernières actualités
actualité
Enquête « Rapport au sexe » (ERAS) 2026 à destination des hommes ayant des...
actualité
Hervé Maisonneuve nommé référent à l’intégrité scientifique pour trois ans
actualité